1. Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up 
Willem P. Brouwer, Henry Lik-Yuen Chan, Maurizia R. Brunetto, Michelle Martinot-Peignoux, Pauline Arends, Markus Cornberg, Beatrice Cherubini, Alex J.V. Thompson, Yun-Fan Liaw, Patrick Marcellin, Harry L.A. Janssen, Bettina E. Hansen 
Clinical Gastroenterology and Hepatology 
Volume 14, Issue 10, Pages e5 (October 2016)
DOI: /j.cgh
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1
Cumulative probability to remain IC during follow-up given HBsAg at inclusion. *HBsAg 100–1000 IU/mL versus >1000 IU/mL: HR, 0.61; 95% CI, 0.3–1.2; P = Two IC patients did not have further follow-up beyond Year 1.
Clinical Gastroenterology and Hepatology  , e5DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Probability of switching given IC (A) or HBV activity (B) and the combination of HBsAg levels in the prior year. Total number of visit-years in this analysis is n = 234 (A) and n = 131 (B). A “visit-year” is a maximum HBV phase and HBsAg level within a follow-up year and thus an umbrella term for multiple visits within a follow-up year.
Clinical Gastroenterology and Hepatology  , e5DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

4. Figure 3
Cumulative probability of HBsAg loss given baseline HBsAg levels. ∗Six patients with HBsAg ≤100 IU/mL lost HBsAg during the first follow-up year, and 26 patients did not have follow-up beyond the first year and were not included in this analysis.
Clinical Gastroenterology and Hepatology  , e5DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

5. Supplementary Figure 1
Schematic example of dynamic regression analysis using a moving timeframe.
Clinical Gastroenterology and Hepatology  , e5DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

6. Supplementary Figure 2
Mean HBsAg level decline from inclusion in inactive carriers versus patients with HBV activity.
Clinical Gastroenterology and Hepatology  , e5DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

7. Supplementary Figure 3
Predicted probability of becoming IC the next year given HBsAg decline and HBV DNA levels.
Clinical Gastroenterology and Hepatology  , e5DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions